The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 22, 2014

Filed:

Dec. 20, 2004
Applicants:

Sant K. Srivastav, Burlington, MA (US);

Suresh C. Srivastava, Burlington, MA (US);

Satya P Bajpai, Krishnalok Lucknow, IN;

Inventors:

Sant K. Srivastav, Burlington, MA (US);

Suresh C. Srivastava, Burlington, MA (US);

Satya P Bajpai, Krishnalok Lucknow, IN;

Assignee:

ChemGenes Corporation, Wilmington, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 19/20 (2006.01); C07H 19/04 (2006.01); C07H 21/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention relates to n-alkylated synthetic nucleosides and phosphoramidites of high regio-specific purity and stability and for selective deprotection of the protecting group in oligonucleotides for the purpose of synthesis of high purity selectively n-alkylated sequence specific DNA and RNA. Such oligonucleotides are useful for study of mechanism of cytotoxic and mutagenic DNA damage, detection and reversal of cellular cytotoxic and mutagenic damages that occurs from the incorporation of methylated nucleosides, the corresponding phosphates and triphosphates and their precursors, via de novo DNA synthesis. The reagents could be extremely valuable tools as diagnostics and mutagenic reversal reagents. The present invention describes N-1-nitrogen alkylated purine and N-3 nitrogen alkylated pyrimidines with appropriate nucleobase amino protection, which are selectively deprotected with minimal migration of the alkyl substituent under the condition which are required for synthesizing high purity regiospecific N-1 and N-3 nitrogen alkylated oligonucleotides. A novel process has been developed to synthesize N-3 nitrogen alkylated cytidine.


Find Patent Forward Citations

Loading…